DEDICATED TO HELPING YOU BRING NEW AND OFF-PATENT DRUGS TO MARKET
Hovione is a Contract Development and Manufacturing Organization (CDMO) with over 65 years of experience and a fully integrated offering from drug substance to drug product intermediate, to drug product.
The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the Inhalation area, Hovione offers a complete range of services, from API, formulation development and devices.
Hovione’s culture is based on innovation, quality and dependability. Hovione is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.
SCHEDULE A MEETING WITH OUR EXPERTS AT AAPS
Get to know how our end-to-end solutions in one site can take your project to market faster.